Skip to main contentSkip to navigationSkip to search

ENDO 2026

Somatostatin Receptor Ligand Adherence and Time to IGF-1 Control in Acromegaly: US Real-World Evidence from Linked Claims and EHR Data

Click the material you wish to view

Somatostatin Receptor Ligand Adherence and Time to IGF-1 Control in Acromegaly

Pdf 0.5 MB

See all posters presented at
ENDO 2026

Explore more

Disease areas

Camurus is committed to improving treatment outcomes and quality of life for people with severe and chronic diseases.

Congresses

Camurus is committed to improving treatment outcomes and quality of life for people with severe and chronic diseases.